Holen Sie sich die Stockscreener-App
1.70
3.66%
0.06
Vorhandelsmarkt:
1.73
0.03
+1.76%
Pacific Biosciences Of California Inc Aktie (PACB) Neueste Nachrichten
Cantor Fitzgerald Comments on PACB FY2025 Earnings - MarketBeat
PACB Stock Falls on Preliminary Q4 Sales Miss, 7 Vega Systems Shipped - MSN
PACB Stock Rises After the Shipment of Vega Systems to Berry Genomics - MSN
RNA Transcriptome Profiling Tests Market Expands at 14.5% CAGR, Surpassing US$ 37 Billion by 2034 | Fact.MR Report - GlobeNewswire Inc.
Chromosome-level genome assembly of the pine wood nematode carrier Arhopalus unicolor - Nature.com
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now - MSN
PacBio announces preliminary Q4 revenue of $39.2M - MSN
Pacific Biosciences of California (NASDAQ:PACB) Shares Gap DownShould You Sell? - MarketBeat
PacBio Stock May Gain Following the Collaborated Launch of GutID - MSN
PACB Stock Declines Despite Promising HiFi Sequencing Findings - Yahoo Finance
Don't Ignore The Insider Selling In Pacific Biosciences of California - Simply Wall St
Selling Pacific Biosciences of California Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - Simply Wall St
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Bought by Barclays PLC - MarketBeat
PacBio reports drop in annual revenue, launches new products By Investing.com - Investing.com Canada
PacBio reports drop in annual revenue, launches new products - Investing.com India
PacBio's HiFi Sequencing Achieves 93% Success Rate in Breakthrough Rare Disease Study - StockTitan
PacBio Announces Preliminary Fourth Quarter and Full Year Revenue - Quantisnow
Pacific Biosciences COO Mark Van Oene sells shares for $69,979 - Investing.com India
Whole genome sequencing, assembly and annotation of the Southern Ground Hornbill – Bucorvus leadbeateri - Nature.com
Pacific Biosciences COO Mark Van Oene sells shares for $69,979 By Investing.com - Investing.com Canada
Insider Selling: Pacific Biosciences of California, Inc. (NASDAQ:PACB) Insider Sells 34,405 Shares of Stock - MarketBeat
Pacbio and Intus Bio Collaborate for Launch of Gutid - Marketscreener.com
PacBio Launches GutID: Revolutionary At-Home Microbiome Test Using HiFi Sequencing - StockTitan
Pacific Biosciences of California (NASDAQ:PACB) Upgraded to Sell at StockNews.com - MarketBeat
PacBio delivers first Vega systems to Berry Genomics By Investing.com - Investing.com Nigeria
PacBio delivers first Vega systems to Berry Genomics - Investing.com
PacBio Announces Shipment of Vega Systems to Berry Genomics to Support its Clinical Assay Development for Asian Markets - Quantisnow
Why the Market Dipped But Pacific Biosciences of California (PACB) Gained Today - MSN
PacBio Delivers First Vega DNA Sequencers to Berry Genomics in Major China Expansion - StockTitan
Pacific Biosciences of California (NASDAQ:PACB) Stock Price Up 7.2%What's Next? - MarketBeat
Pacific Biosciences of California Sees Unusually Large Options Volume (NASDAQ:PACB) - MarketBeat
PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference - Quantisnow
Barclays PLC Boosts Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB) - MarketBeat
Chromosome-level genome assembly of Triplophysa bombifrons using PacBio HiFi sequencing and Hi-C technologies - Nature.com
Why Is Pacific Biosciences of California, Inc. (PACB) Among the Top CRISPR Stocks to Invest In? - Insider Monkey
Top 11 CRISPR Stocks to Invest In - Insider Monkey
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives $2.95 Consensus Target Price from Analysts - MarketBeat
State Street Corp Boosts Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB) - MarketBeat
Third Generation Sequencing Market Key Players Analysis - openPR
Reasons to Retain PacBio Stock in Your Portfolio for Now - MSN
China Neurogenomics Market Research 2024-2031, Profiles of Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche, MGI Tech, Agilent, Revvity, Qiagen, Pacific Biosciences, Danaher, Oxford NanoporeResearchAndMarkets.com - WICZ
Fmr LLC Has $694,000 Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB) - MarketBeat
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):